U.S. Wireless Telecom Stock News

NYSE:TFX
NYSE:TFXMedical Equipment

Does Teleflex's (TFX) Leadership Turmoil Recast the Story on Governance and Operational Resilience?

Teleflex announced it would host a conference call on February 26, 2026, to review its fourth-quarter 2025 results and provide an operational update, with live and replay audio available via the company’s website. This update comes soon after the abrupt departure of CEO Liam Kelly and the launch of a securities fraud investigation, raising fresh questions about governance and operational continuity. We’ll now examine how the CEO’s immediate departure and related securities fraud...
NasdaqGS:CENT
NasdaqGS:CENTHousehold Products

Central Garden And Pet Buyback Expansion And New Director Refocus Investor Attention

Central Garden & Pet (NasdaqGS:CENT) expanded its stock repurchase program by an additional US$100 million. The company also appointed Kay M. Schwichtenberg, an industry executive with over 40 years of experience, to its Board of Directors. These board and capital allocation moves are recent developments that have not yet been widely discussed by investors. Central Garden & Pet, known for its pet and garden products portfolio, sits in the middle of long term trends such as rising pet...
NasdaqGS:FSLR
NasdaqGS:FSLRSemiconductor

Assessing First Solar (FSLR) Valuation As Short Interest Declines And Sentiment Shows Signs Of Improvement

Short interest in First Solar (FSLR) has fallen 10.09%, with 7.59 million shares now sold short, or 9.09% of the float. This has prompted fresh questions about shifting sentiment around the stock. See our latest analysis for First Solar. At a share price of $238.57, First Solar has seen a 5.54% 1 day share price return and a 4.76% 7 day share price return, while the year to date share price return is a 13.04% decline and the 1 year total shareholder return is 46.81%. This suggests that...
NYSE:NHI
NYSE:NHIHealth Care REITs

A Look At National Health Investors (NHI) Valuation After New Property Acquisitions And Analyst Rating Upgrade

National Health Investors (NHI) recently hit a 52 week high of $90.58 after announcing plans to acquire nine healthcare properties for $105.5 million, as well as additional investments across Kentucky, South Carolina, and Tennessee. See our latest analysis for National Health Investors. The recent property acquisitions come after a strong run, with the share price at $88.95 posting a 30 day share price return of 10.95% and a year to date share price return of 15.75%. The 1 year total...
NYSE:KO
NYSE:KOBeverage

Coca-Cola Leadership Shift Puts Digital Focus And Valuation In Spotlight

Coca-Cola (NYSE:KO) has announced that Henrique Braun will become CEO, marking a major leadership transition at the company. The company is also creating a new Chief Digital Officer role, focused on digital transformation and faster innovation across its global operations. These leadership changes are positioned as a shift toward stronger digital capabilities and closer alignment with local market needs. Coca-Cola, known for its global beverage portfolio, is making this move as consumer...
NYSE:O
NYSE:ORetail REITs

Realty Income’s Logistics And Gaming Shift Versus Valuation And Dividend Priorities

Realty Income (NYSE:O) is expanding beyond its traditional property mix with new commitments in logistics and gaming assets. The company recently announced a $1.5 billion partnership focused on logistics properties and an $800 million preferred equity investment in gaming real estate. These moves mark a shift in how Realty Income is positioning its portfolio for future income sources. Realty Income, trading at around $65.07 per share, has delivered a 23.6% return over the past year and...
NasdaqGS:PFG
NasdaqGS:PFGInsurance

How Principal’s Higher Dividend and US$1.5 Billion Buybacks Will Impact Principal Financial Group (PFG) Investors

Principal Financial Group, Inc. recently announced a first-quarter 2026 cash dividend of US$0.80 per share, a one-cent increase over the prior quarter and 7% higher than the same period a year earlier, alongside updates that it completed share repurchases totaling 16,965,356 shares for US$1.50 billion across previously announced buyback programs. The company also reported full-year 2025 revenue of US$15,625.5 million and net income of US$1,185.1 million, framing its higher dividend and...
NYSE:SUI
NYSE:SUIResidential REITs

Is Sun Communities (SUI) Offering Value After Mixed Multi Year Share Price Performance

Wondering if Sun Communities at around US$129.99 is offering fair value or a potential mispricing opportunity? This article walks you through what the numbers actually suggest. The stock has returned 1.7% over the last 7 days, 6.4% year to date and 10.9% over the last year, while the 30 day return sits at a slight 0.2% decline and the 3 and 5 year returns are 4.4% and 0.9% declines respectively. Recent coverage of Sun Communities has focused on its role as a large US real estate owner and...
NYSE:IVZ
NYSE:IVZCapital Markets

Invesco Earnings Beat Meets Share Weakness As UK Equity Push Grows

Invesco (NYSE:IVZ) reported quarterly results that exceeded revenue and earnings expectations, yet the share price fell sharply after the announcement. A senior Invesco strategist has been publicly promoting UK equities as an attractive way to diversify portfolios, citing changing global market conditions. These developments highlight a gap between recent company performance and investor reaction, alongside a clear view from Invesco on regional equity positioning. Invesco, a global asset...
NYSE:KBR
NYSE:KBRProfessional Services

Assessing KBR (KBR) Valuation After New 10 Year AI Enabled Petro Rabigh Maintenance Deal

KBR (KBR) shares are in focus after the company agreed to a 10 year general maintenance services contract with Petro Rabigh, using AI and machine learning tools to support key polymer plants in Saudi Arabia. See our latest analysis for KBR. KBR’s recent client wins in Saudi petrochemicals and US space programs come against a mixed backdrop, with a 1 day share price return of 2.16% and a 1 year total shareholder return decline of 17.23%, while the 5 year total shareholder return of 36.67%...
NYSE:TOST
NYSE:TOSTDiversified Financial

Is Toast (TOST) Pricing Look Attractive After Recent Share Price Weakness

If you are wondering whether Toast's current share price still makes sense, you are not alone. This article will walk through what the market might be pricing in today and how that lines up with different valuation checks. Toast's share price closed at US$27.67, with returns of a 1.2% decline over the last 7 days, a 17.5% decline over 30 days, an 18.7% decline year to date and a 30.8% decline over the past year, set against a 37.3% return over the last 3 years. Recent headlines around Toast...
NasdaqGS:PLTK
NasdaqGS:PLTKEntertainment

A Look At Playtika Holding (PLTK) Valuation After Credit Facility Refinance And Cost-Cutting Measures

What Playtika’s New Credit Facility Means for Investors Playtika Holding (PLTK) has amended and refinanced its existing revolving credit facility, keeping the size at $550 million while extending the maturity to March 2027 and maintaining similar terms. This debt move arrives alongside reaffirmed full year revenue and adjusted EBITDA guidance and ongoing cost cuts, including a planned 15% workforce reduction as the company increases its use of AI automation. See our latest analysis for...
NYSE:DBRG
NYSE:DBRGCapital Markets

Reassessing DigitalBridge Group (DBRG) After Its 44% One-Year Share Price Surge

If you are wondering whether DigitalBridge Group is still attractively priced after its recent run, looking closely at its valuation metrics can help you decide what the current share price really offers. The stock last closed at US$15.41, with returns of 0.0% over 7 days, 0.4% over 30 days, 0.2% year to date, 43.9% over 1 year, 13.5% over 3 years, and a 36.3% decline over 5 years. Taken together, these figures give a mixed picture of how the market has treated the shares over different...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

Assessing Mirum Pharmaceuticals (MIRM) Valuation After Recent Share Price Momentum And Rare Disease Growth Prospects

Mirum Pharmaceuticals: Stock Moves and Business Snapshot Mirum Pharmaceuticals (MIRM) has seen its share price move recently, and investors are revisiting the biopharma name with its focus on rare and orphan liver diseases and a growing commercial portfolio. See our latest analysis for Mirum Pharmaceuticals. The recent 2.2% 1 day share price return, 15.4% 30 day share price return and very large 5 year total shareholder return suggest momentum has been building for Mirum, as investors react...
NasdaqGS:TMUS
NasdaqGS:TMUSWireless Telecom

T-Mobile US (TMUS) Valuation Check After AI Network Launch Earnings Update And Euro Bond Issuance

Earnings, AI launch, and bond deals put T-Mobile US (TMUS) in focus T-Mobile US (TMUS) is back in the spotlight after unveiling a real-time agentic AI platform inside its network, pairing that launch with fresh 2025 results, 2026 guidance, and multi tranche euro bond offerings. See our latest analysis for T-Mobile US. The share price has been strong in the near term, with a 14.45% 1 month share price return and a 6.85% year to date share price return, while the 1 year total shareholder return...
NasdaqGS:BTSG
NasdaqGS:BTSGHealthcare

BrightSpring Index Additions And Specialty Drug Deals Draw Valuation Focus

BrightSpring Health Services (NasdaqGS:BTSG) has been added to several S&P indices, including the S&P SmallCap 600 and S&P Composite 1500. The index changes highlight growing attention from institutional investors toward the company. Recent contract wins for high margin specialty drugs serving complex conditions are supporting business momentum. BrightSpring operates in healthcare services and specialty pharmaceuticals, areas that sit at the intersection of aging demographics, chronic...